Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 1, 2008, Pages 306-311

  Moore, Brioni R ^a   Batty, Kevin T ^a   Andrzejewski, Christopher ^a   Jago, Jeffrey D ^a   Page Sharp, Madhu ^b   Ilett, Kenneth F ^b,c  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROARTEMISININ; PIPERAQUINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENTIATION; MALARIA; MALE; MOUSE; NONHUMAN; PARASITEMIA; PHARMACODYNAMICS; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; HUMANS; MALARIA; MALE; MICE; PARASITEMIA; PLASMODIUM BERGHEI; QUINOLINES; SESQUITERPENES; TREATMENT OUTCOME;

EID: 37849002525     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00878-07     Document Type: Article

References (29)

1. Ashley, E. A., S. Krudsood, L. Phaiphun, S. Srivilairit, R. McGready, W. Leowattana, R. Hutagalung, P. Wilairatana, A. Brockman, S. Looareesuwan, F. Nosten, and N. J. White. 2004. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. J. Infect. Dis. 190:1773-1782.
2. Ashley, E. A., R. McGready, R. Hutagalung, L. Phaiphun, T. Slight, S. Proux, K. L. Thwai, M. Barends, S. Looareesuwan, N. J. White, and F. Nosten. 2005. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin. Infect. Dis. 41:425-432.
3. Bailer, J. A. 1988. Testing for the equality of area under the curves when using destructive measurement techniques. J. Pharmacokinet. Biopharm. 16:303-309.
4. Basco, L. K., and P. Ringwald. 2003. In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon. Antimicrob. Agents Chemother. 47:1391-1394.
5. Chen, L. 1991. Recent studies on antimalarial efficacy of piperaquine and hydroxypiperaquine. Chin. Med. J. 104:161-163.
6. Chen, L., Q. Feng-Yi, and Z. Yang-Chang. 1982. Field observations of the antimalarial piperaquine. Chin. Med. J. 95:281-286.
7. Davis, T. M. E., J. Hamzah, K. F. Ilett, H. A. Karunajeewa, J. C. Reeder, K. T. Batty, S. Hackett, and P. H. R. Barrett. 2006. In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs. Antimicrob. Agents Chemother. 50:2883-2885.
8. Davis, T. M. E., T. Y. Hung, I. K. Sim, H. A. Karunajeewa, and K. F. Ilett. 2005. Piperaquine: a resurgent antimalarial drug. Drugs 65:75-87.
9. Denis, M. B., T. M. E. Davis, S. Hewitt, S. Incardona, K. Nimol, T. Fandeur, Y. Poravuth, C. Lim, and D. Socheat. 2002. Efficacy and safety of dihydro-artemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin. Infect. Dis. 35:1469-1476.
10. Hasugian, A. R., H. L. E. Purba, R. M. Wuwung, E. P. Ebsworth, R. Maristela, P. M. P. Penttinen, F. Laihad, N. M. Anstey, and R. N. Price. 2007. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin. Infect. Dis. 44:1067-1074.
11. Hung, T.-Y., T. M. E. Davis, and K. F. Ilett. 2003. Measurement of piperaquine in plasma by liquid chromatography with ultraviolet absorbance detection. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 791:93-101.
12. Hung, T. Y., T. M. E. Davis, K. Ilett, H. Karunajeewa, S. Hewitt, M. B. Denis, C. Lim, and D. Socheat. 2004. Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria. Br. J. Clin. Pharmacol. 57:253-262.
13. Janssens, B., M. van Herp, L. Goubert, S. Chan, S. Uong, S. Nong, D. Socheat, A. Brockman, E. A. Ashley, and W. Van Damme. 2007. A randomized open study to assess the efficacy and tolerability of dihydroartemisinin- piperaquine for the treatment of uncompromised falciparum malaria in Cambodia. Trop. Med. Int. Health 12:251-259.
14. Karema, C., C. I. Fanello, C. Van Overmeir, J.-P. Van Geertruyden, W. van Doren, D. Ngamije, and U. D'Alessandro. 2006. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Trans. R. Soc. Trop. Med. Hyg. 100:1105-1111.
15. Karunajeewa, H., C. Lim, T.-Y. Hung, K. F. Ilett, M. B. Denis, D. Socheat, and T. M. E. Davis. 2004. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Br. J. Clin. Pharmacol. 57:93-99.
16. Lewis, S. M., B. J. Bain, and I. Bates. 2001. Dacie and Lewis's practical haematology, 9th ed. Churchill Livingstone, London, United Kingdom.
17. Myint, H. Y., E. A. Ashley, N. P. J. Day, F. Nosten, and N. J. White. 2007. Efficacy and safety of dihydroartemisinin-piperaquine. Trans. R. Soc. Trop. Med. Hyg. 101:858-866.
18. Piyaphanee, W., S. Krudsood, N. Tangpukdee, W. Thanachartwet, U. Silachamroon, N. Phophak, C. Duangdee, O. Haoharn, S. Faithong, P. Wilairatana, W. Leowattana, and S. Looareesuwan. 2006. Emergence and clearance of gametocytes in uncomplicated Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 74:432-435.
19. Qu, F., J. Li, and N. Wang. 1981. Prophylactic and therapeutic effects of piperaquine and its compounds on Plasmodium berghei. Pharm. Ind. 12:19-21.
20. Ratcliff, A., H. Siswantoro, E. Kenangalem, R. Maristela, R. M. Wuwung, F. Laihad, E. P. Ebsworth, N. M. Anstey, E. Tijitra, and R. N. Price. 2007. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomized comparison. Lancet 369:757-765.
21. Röshammar, D., T. N. Hai, S. F. Hietala, N. V. Huong, and M. Ashton. 2006. Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects. Eur. J. Clin. Pharmacol. 62:335-341.
22. Sharp, P. E., and M. C. La Regina. 1998. The laboratory rat. CRC Press, Inc., Boca Raton, FL.
23. Sim, I.-K., T. M. E. Davis, and K. F. Ilett. 2005. Effects of a high-fat meal on the relative oral bioavailability of piperaquine. Antimicrob. Agents Chemother. 49:2407-2411.
24. Smithuis, F., M. K. Kyaw, O. Phe, K. Z. Aye, L. Htet, M. Barends, N. Lindegardh, T. Singtoroj, E. Ashley, S. Lwin, K. Stepniewska, and N. J. White. 2006. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomized comparison. Lancet 367:2075-2085.
25. Suckow, M. A., P. Danneman, and C. Brayton. 2001. The laboratory mouse. CRC Press, Inc., Boca Raton, FL.
26. Tangpukdee, N., S. Krudswood, K. Chalermrut, C. Pengruksa, S. Sriviairit, U. Silachamroon, P. Wilairtana, S. Phongtananant, S. Kano, and S. Looareesuwan. 2005. An open, randomized clinical trial of Artekin versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Southeast Asian J. Trop. Med. Public Health 36:1085-1091.
27. Tran, T. H., C. Dolecek, P. M. Pham, T. D. Nguyen, T. T. Nguyen, H. T. Le, T. H. Dong, T. T. Tran, K. Stepniewska, N. J. White, and J. Farrar. 2004. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomized clinical trial. Lancet 363:18-22.
28. White, N. J. 1999. Antimalarial drug resistance and combination chemotherapy. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354:739-749.
29. Yuan, J. 1993. Estimation of variance for AUC in animal studies. J. Pharm. Sci. 82:761-763.